Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis
出版年份 2023 全文链接
标题
Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-02-03
DOI
10.3389/fphar.2023.1089812
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
- (2021) Alison E. John et al. IMMUNOLOGICAL REVIEWS
- Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis
- (2021) Martina Milani et al. Journal of Neuroinflammation
- Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
- (2021) Demin Cheng et al. Journal of Translational Medicine
- Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1
- (2021) Xuan Gu et al. PHARMACOLOGICAL RESEARCH
- Extracellular S100A4 as a key player in fibrotic diseases
- (2020) Zhenzhen Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
- (2020) Uddalak Bharadwaj et al. PHARMACOLOGICAL REVIEWS
- Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis
- (2020) Rajesh K Kasam et al. EMBO Molecular Medicine
- Spectrum of Fibrotic Lung Diseases
- (2020) Marlies Wijsenbeek et al. NEW ENGLAND JOURNAL OF MEDICINE
- The S100 calcium-binding protein A4 level is elevated in the lungs of patients with idiopathic pulmonary fibrosis
- (2020) Jong-Uk Lee et al. RESPIRATORY MEDICINE
- S100A4 promotes inflammation but suppresses lipid accumulation via the STAT3 pathway in chronic ethanol-induced fatty liver
- (2019) Qi Yuan et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis
- (2019) Vahid Kheirollahi et al. Nature Communications
- Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways
- (2019) Yuting Zhang et al. PHARMACOLOGICAL RESEARCH
- The therapy of idiopathic pulmonary fibrosis: what is next?
- (2019) Vivien Somogyi et al. European Respiratory Review
- Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression
- (2019) David C. Yang et al. FASEB JOURNAL
- Downregulation of S100A4 Alleviates Cardiac Fibrosis via Wnt/β -Catenin Pathway in Mice
- (2018) LiJun Qian et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Effects of metformin on the expression of AMPK and STAT3 in the spinal dorsal horn of rats with neuropathic pain
- (2018) Anqi Ge et al. Molecular Medicine Reports
- Metformin reverses established lung fibrosis in a bleomycin model
- (2018) Sunad Rangarajan et al. NATURE MEDICINE
- S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes Activation of Lung Fibroblasts in Pulmonary Fibrosis
- (2018) Wei Zhang et al. Frontiers in Immunology
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2018) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- S100 proteins in rheumatic diseases
- (2018) Judith Austermann et al. Nature Reviews Rheumatology
- The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis
- (2018) Ariella Zehender et al. Nature Communications
- S100A4+ Macrophages Are Necessary for Pulmonary Fibrosis by Activating Lung Fibroblasts
- (2018) Yanan Li et al. Frontiers in Immunology
- Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis
- (2017) Hong Xia et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin Suppresses Systemic Autoimmunity inRoquinsan/sanMice through Inhibiting B Cell Differentiation into Plasma Cells via Regulation of AMPK/mTOR/STAT3
- (2017) Seon-Yeong Lee et al. JOURNAL OF IMMUNOLOGY
- Idiopathic pulmonary fibrosis
- (2017) Luca Richeldi et al. LANCET
- Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
- (2017) Debomita Chakraborty et al. Nature Communications
- Role of metastasis-induced protein S100A4 in human non-tumor pathophysiologies
- (2017) Fei Fei et al. Cell and Bioscience
- STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation
- (2016) Mesias Pedroza et al. FASEB JOURNAL
- Involvement of fibroblast-specific protein 1 (S100A4) and matrix metalloproteinase-13 (MMP-13) in CCl4-induced reversible liver fibrosis
- (2016) Manal L. Louka et al. GENE
- S100A4 promotes liver fibrosis via activation of hepatic stellate cells
- (2015) Lin Chen et al. JOURNAL OF HEPATOLOGY
- S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis
- (2014) Michal Tomcik et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis
- (2013) Ping Kong et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver
- (2010) C. H. Osterreicher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STAT3 in tissue fibrosis: Is there a role in the lung?
- (2010) Darryl Knight et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- S100A4: a common mediator of epithelial–mesenchymal transition, fibrosis and regeneration in diseases?
- (2008) Mikael Schneider et al. JOURNAL OF MOLECULAR MEDICINE-JMM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search